12-29-5-1　ⓔ文献

  1. Tanaka M, Fernandez–Del Castillo C, et al: Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology, 2017; 17: 738–753.

  2. Basturk O, Hong SM, et al: A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol, 2015; 39: 1730–1741.

  3. Furukawa T, Klöppel G, et al: Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch, 2005; 447: 794–799.

  4. Furukawa T, Kuboki Y, et al: Whole–exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep, 2011; 1: 161.

  5. Kuboki Y, Shimizu K, et al: Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Pancreas, 2015; 44: 227–235.

  6. Komatsu H, Tanji E, et al: A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes. PLoS One, 2014; 9: e87875.

  7. Taki K, Ohmuraya M, et al: GNAS (R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm. Oncogene, 2016; 35: 2407–2412.

  8. Furukawa T, Hatori T, et al: Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut, 2011; 60: 509–516.

  9. Basturk O, Esposito I, et al: Pancreatic intraductal papillary mucinous neoplasm, in WHO Classification of Tumours Digestive System Tumours, The WHO Classification of Tumours Editorial Board, Editor. 2019, International Agency for Research on Cancer: Lyon, 310–314.

  10. Tanaka M, Chari S, et al: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology, 2006; 6: 17–32.

  11. Tanaka M, Fernandez–del Castillo C, et al: International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology, 2012; 12: 183–197.

  12. Monzen M, Shimizu K, et al: Usefulness of cell block cytology for preoperative grading and typing of intraductal papillary mucinous neoplasms. Pancreatology, 2013; 13: 369–378.

  13. Yamaguchi H, Shimizu M, et al: Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol, 2009; 33: 1164–1172.